IDO2: A Pathogenic Mediator of Inflammatory Autoimmunity

Indoleamine 2,3-dioxygenase 2 (IDO2), a homolog of the better-studied tryptophan-catabolizing enzyme IDO1, is an immunomodulatory molecule with potential effects on various diseases including cancer and autoimmunity. Here, we review what is known about the direct connections between IDO2 and immune...

Повний опис

Збережено в:
Бібліографічні деталі
Автори: Lauren M.F. Merlo (Автор), Laura Mandik-Nayak (Автор)
Формат: Книга
Опубліковано: SAGE Publishing, 2016-01-01T00:00:00Z.
Предмети:
Онлайн доступ:Connect to this object online.
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_2da27fba57c045b4ac2aa183ac357ee8
042 |a dc 
100 1 0 |a Lauren M.F. Merlo  |e author 
700 1 0 |a Laura Mandik-Nayak  |e author 
245 0 0 |a IDO2: A Pathogenic Mediator of Inflammatory Autoimmunity 
260 |b SAGE Publishing,   |c 2016-01-01T00:00:00Z. 
500 |a 1179-5557 
500 |a 10.4137/CPath.S39930 
520 |a Indoleamine 2,3-dioxygenase 2 (IDO2), a homolog of the better-studied tryptophan-catabolizing enzyme IDO1, is an immunomodulatory molecule with potential effects on various diseases including cancer and autoimmunity. Here, we review what is known about the direct connections between IDO2 and immune function, particularly in relationship to autoimmune inflammatory disorders such as rheumatoid arthritis and lupus. Accumulating evidence indicates that IDO2 acts as a pro-inflammatory mediator of autoimmunity, with a functional phenotype distinct from IDO1. IDO2 is expressed in antigen-presenting cells, including B cells and dendritic cells, but affects inflammatory responses in the autoimmune context specifically by acting in B cells to modulate T cell help in multiple model systems. Given that expression of IDO2 can lead to exacerbation of inflammatory responses, IDO2 should be considered a potential therapeutic target for autoimmune disorders. 
546 |a EN 
690 |a Pathology 
690 |a RB1-214 
655 7 |a article  |2 local 
786 0 |n Clinical Medicine Insights: Pathology, Vol 9s1 (2016) 
787 0 |n https://doi.org/10.4137/CPath.S39930 
787 0 |n https://doaj.org/toc/1179-5557 
856 4 1 |u https://doaj.org/article/2da27fba57c045b4ac2aa183ac357ee8  |z Connect to this object online.